INTRODUCTION
Abnormal uterine bleeding is a common gynaecological symptom. In peri-and postmenopausal women it is essential to exclude endometrial carcinoma although the incidence is only 6.96 per 1000 women with post menopausal bleeding.' In younger women, endometrial hyperplasia and anatomical anomalies, such as uterine fibroids, comprise the main pathology. 2 The recommendation regarding investigation of abnormal uterine bleeding from the Royal College of Obstetricians and Gynaecologists is that women, over the age of45, should be investigated with hysteroscopy and endometrial biopsy. 3 Frequently, this is performed as an inpatient procedure with the biopsy being obtained by uterine curettage (D&C). Blind sharp curettage covers as much as 60% of the cavity but may miss polyps as they recoil from the passing curette. 4 However, inpatient investigations are costly and there are risks associated with the use of general anaesthesia. Outpatient alternatives to D&C include microhysteroscopy (either flexible or rigid), transvaginal ultrasonography, with or without saline infusion (sonohysterography) and endometrial biopsy. Transvaginal ultrasonography is useful in determining endometrial thickness and morphology as well as the regularity of the endo/myometrial border.' Whilst the procedure is well tolerated by patients, sessile or pedunculated lesions of the endometrium and malignant disease cannot be definitively excluded.6 7 However, it has been reported that post-menopausal malignant disease is very unlikely when the endometrial thickness is less than 5 mm and the patient is not taking hormone replacement therapy (HRT).8 Vaginal sonohysterography is a modification of vaginal ultrasound in which a small volume of saline is injected into the uterine cavity during ultrasound examination.9 This enables irregularities of the endo/myometrial border and the free endometrial border to be more easily visualised.10 Outpatient endometrial sampling devices have a narrow bore (typically about 3 mm external diameter) and sample the endometrium by aspiration. Although they pass relatively easily through the cervical canal, there may be associated pain when the sample is harvested and, unlike directed biopsy, the sample is obtained blind. As little as 4% of the cavity may be sampled and polypoid lesions are unlikely to be removed.11 However, the reported sensitivity for detecting endometrial abnormality is approximately 85% 12, 13 Outpatient hysteroscopy is both feasible and highly acceptable in the majority of patients, giving a high detection rate for intrauterine pathology.'4"5 It allows the operator to take a directed biopsy and is more specific and sensitive than transvaginal ultrasound or blind endometrial sampling. As an investigation for abnormal uterine bleeding it was recommended by both the Royal College of Obstetricians and Gynaecologists and the American College of Obstetricians and Gynecologists in 1994.3 16 However, it is significantly less easily performed than either ultrasound or biopsy. Therefore, a means of selecting patients by, for example, menopausal status, symptomatology and associated clinical findings might lead to a more efficient use of hysteroscopy than a blanket recommendation that all cases of abnormal bleeding should undergo the procedure. Our aim was to develop a nomogram using historical information, ultrasound and biopsy results to select those women who should have a formal hysteroscopic evaluation.
METHODS
The charts of 100 consecutive referrals for outpatient hysteroscopy from the general gynaecology clinics at the Royal Group of Hospitals' Trust, Belfast, were reviewed. The decision to refer was made by the patient's consultant: there were no defined guidelines for referral: a number of patients had vaginal ultrasound scan and endometrial biopsy at the outpatient clinic prior to referral (these procedures were repeated at the outpatient hysteroscopy clinic). The indication for the procedure, the subject's age, parity, menstrual status and outcome of the investigation were recorded. All of the procedures were performed by a single operator. Whilst the data was recorded prospectively at the time of consultation it was analysed retrospectively. The examination of each subject followed a standard protocol. The patient was placed in the lithotomy position with her ankles supported by stirrups. A bimanual vaginal examination was performed to note the size, position and shape of the uterus and the presence or absence of adnexal pathology. Vaginal ultrasound examination using a 5 MHz probe (FF Sonic, Fukuda Denshi, Japan) was performed to determine the dual endometrial thickness (ET), that is, the perpendicular distance from one endo/myometrial border to the other at its widest part in longitudinal section, and to identify endometrial polypoid lesions, free fluid or fibroids. For the hysteroscopy a Simm's speculum was inserted into the vagina and the cervix grasped with a single toothed tenaculum forceps. A 3.4 mm external diameter Hamou Microhysteroscope (Karl Storz, Tuttlingen, Germany) was passed through the cervix, under direct vision, into the uterine cavity which was distended by carbon dioxide via a hysteroflator (Karl Storz) set at maximum pressure 75 mmHg and flow rate of 200 mls/minute. The cavity was illuminated by a Coldlight Fountain (Karl Storz) and the images displayed on a Sony Trinitron monitor using a Telecam Pal single chip camera system (Karl Storz). The endometrium was serially inspected for pathology. When the inspection of the cavity was complete the gas and scope were removed from the uterus. Finally, a Pipelle endometrial sampler was used to obtain a biopsy of the endometrium using no more than two attempts at sample aspiration. The specimen was placed in formalin and sent for histopathological analysis. Neither analgesia or anaesthesia was routinely used and was not required by any patient in this series. The histological and ultrasound diagnoses were combined to formulate a working ultrasound/ biopsy diagnosis and this was compared with a similarly combined hysteroscopy/biopsy diagnosis.
RESULTS
The average age of the patients referred was 48.5 years (29-78). Six subjects were nulliparous, six were grand multiparas and the remainder had had ). When a cut-off value of 5 mm for ET in post-menopausal women not taking HRT is taken, vaginal ultrasound/biopsy achieved a sensitivity of 100%. The 10 mm ET cut off for pre-, peri-and postmenopausal women taking HRT, has a lower sensitivity, however, the positive predictive value is increased (i.e. when pathology was diagnosed, it was more often present).
DISCUSSION
This is the first prospective comparison of transvaginal ultrasound with biopsy versus outpatient hysteroscopy with biopsy in a patient population with both pre-and postmenopausal patients. A single operator who had considerable experience in each technique performed all ofthe procedures. The subject body constituted 100 consecutive referrals from seven gynaecologists: the decision to refer was taken by the clinicians on an individual basis and no specific criteria were set. The patients included were those whom the referring gynaecologists felt were likely to have pathology and to require a more thorough evaluation than could be offered by ultrasound and biopsy alone. As the purpose of this study was to develop a nomogram for evaluation of patients with abnormal pre-or postmenopausal bleeding, we feel that this enhanced the power of the study by including only those likely to have pathology.
In the literature to date, there have been numerous reports examining the role of ultrasound or hysteroscopy but without biopsy. 
